Cargando…
When one cell is enough
For many years, the hematopoietic stem cell (HSC) has been well characterized in mice as a cell that can singly reconstitute the whole hematopoietic system of primary recipient animals as well as that of secondary hosts. That clinical bone marrow transplantation is a successful treatment strategy is...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340545/ https://www.ncbi.nlm.nih.gov/pubmed/22264381 http://dx.doi.org/10.1186/scrt92 |
_version_ | 1782231471246802944 |
---|---|
author | Ceredig, Rhodri |
author_facet | Ceredig, Rhodri |
author_sort | Ceredig, Rhodri |
collection | PubMed |
description | For many years, the hematopoietic stem cell (HSC) has been well characterized in mice as a cell that can singly reconstitute the whole hematopoietic system of primary recipient animals as well as that of secondary hosts. That clinical bone marrow transplantation is a successful treatment strategy is indirect evidence that such a cell exists in humans. To date, similar criteria have not been applied to human HSCs. However, using a humanized mouse model of xenotransplantation, a recent paper shows that single human cells can fully reconstitute the lymphomyeloid system of primary recipient animals and, in some cases, that of secondary hosts. |
format | Online Article Text |
id | pubmed-3340545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33405452013-01-13 When one cell is enough Ceredig, Rhodri Stem Cell Res Ther Commentary For many years, the hematopoietic stem cell (HSC) has been well characterized in mice as a cell that can singly reconstitute the whole hematopoietic system of primary recipient animals as well as that of secondary hosts. That clinical bone marrow transplantation is a successful treatment strategy is indirect evidence that such a cell exists in humans. To date, similar criteria have not been applied to human HSCs. However, using a humanized mouse model of xenotransplantation, a recent paper shows that single human cells can fully reconstitute the lymphomyeloid system of primary recipient animals and, in some cases, that of secondary hosts. BioMed Central 2012-01-13 /pmc/articles/PMC3340545/ /pubmed/22264381 http://dx.doi.org/10.1186/scrt92 Text en Copyright ©2012 BioMed Central Ltd |
spellingShingle | Commentary Ceredig, Rhodri When one cell is enough |
title | When one cell is enough |
title_full | When one cell is enough |
title_fullStr | When one cell is enough |
title_full_unstemmed | When one cell is enough |
title_short | When one cell is enough |
title_sort | when one cell is enough |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340545/ https://www.ncbi.nlm.nih.gov/pubmed/22264381 http://dx.doi.org/10.1186/scrt92 |
work_keys_str_mv | AT ceredigrhodri whenonecellisenough |